1-03-2023, 13:01

Sequana Medical announces positive results from CHIHUAHUA,

PRESS RELEASE Phase 1 clinical trial (CHIHUAHUA) demonstrates that single dose of second-generation DSR product (DSR
Globe Newswire1-03-2023, 13:01
9-02-2023, 13:07

Sequana Medical announces 2022 Full Year Results and 2023

PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® – successful primary endpoint read-out of
Globe Newswire9-02-2023, 13:07
1-02-2023, 13:02

Sequana Medical announces grant of additional DSR® patent

PRESS RELEASE Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the
Globe Newswire1-02-2023, 13:02